1. Home
  2. CLDI vs MSS Comparison

CLDI vs MSS Comparison

Compare CLDI & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$0.15

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Logo Maison Solutions Inc.

MSS

Maison Solutions Inc.

HOLD

Current Price

$0.73

Market Cap

3.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
MSS
Founded
2014
2019
Country
United States
United States
Employees
29
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.2M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CLDI
MSS
Price
$0.15
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.50
AVG Volume (30 Days)
3.3M
690.6K
Earning Date
05-14-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.84
EPS
N/A
N/A
Revenue
N/A
$124,217,480.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
114.01
52 Week Low
$0.12
$0.11
52 Week High
$7.32
$3.96

Technical Indicators

Market Signals
Indicator
CLDI
MSS
Relative Strength Index (RSI) 39.60 42.61
Support Level $0.12 $0.65
Resistance Level $0.18 $0.78
Average True Range (ATR) 0.02 0.09
MACD 0.00 -0.01
Stochastic Oscillator 43.13 20.94

Price Performance

Historical Comparison
CLDI
MSS

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: